TOP NEWS: US FDA accepts GSK's new drug application for momelotinib
(Alliance News) - GSK PLC on Wednesday said the US Food & Drug Administration has accepted the new drug application for its momelotinib, which could potentially treat a rare blood cancer myelofibrosis. Read More